Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-11-21 Sale | 2023-11-22 7:00 pm | Olema Pharmaceuticals Inc. | OLMA | Myles David C. CH. DISCOV. & NON-CLIN DEV OFF | 13,629 | $14.4 | $196,233 | 741,776 (Indirect Direct) | View |
| 2023-11-08 Sale | 2023-11-13 5:30 pm | Olema Pharmaceuticals Inc. | OLMA | Myles David C. CH. DISCOV. & NON-CLIN DEV OFF | 200 | $17.61 | $3,522 | 728,947 (Indirect Direct) | View |
| 2023-11-01 Sale | 2023-11-03 9:39 pm | Olema Pharmaceuticals Inc. | OLMA | Myles David C. CH. DISCOV. & NON-CLIN DEV OFF | 10,541 | $15.26 | $160,806 | 729,147 (Indirect Direct) | View |
| 2023-09-19 Sale | 2023-09-21 5:00 pm | Olema Pharmaceuticals Inc. | OLMA | Myles David C. CH. DISCOV. & NON-CLIN DEV OFF | 20,000 | $12.67 | $253,400 | 739,688 (Indirect Direct) | View |
| 2021-12-10 Sale | 2021-12-14 4:03 pm | Olema Pharmaceuticals Inc. | OLMA | Myles David C. CHIEF DEVELOPMENT OFFICER | 10,000 | $10.3 | $103,000 | 750,578 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-02-01 Option Award | 2024-02-05 5:30 pm | N/A 2034-01-31 | Olema Pharmaceuticals Inc. | OLMA | Myles David C. CH. DISCOV. & NON-CLIN DEV OFF | 195,000 | $0 | 195,000 (Direct) | View |
| 2023-11-20 Option Award | 2023-11-22 7:00 pm | N/A N/A | Olema Pharmaceuticals Inc. | OLMA | Myles David C. CH. DISCOV. & NON-CLIN DEV OFF | 26,250 | $0 | 741,776 (Direct) | View |
| 2023-02-01 Option Award | 2023-02-02 5:32 pm | N/A 2033-01-31 | Olema Pharmaceuticals Inc. | OLMA | Myles David C. Chief Development Officer | 150,000 | $0 | 150,000 (Direct) | View |
| 2022-02-01 Option Award | 2022-02-03 7:15 pm | N/A 2032-01-31 | Olema Pharmaceuticals Inc. | OLMA | Myles David C. CHIEF DEVELOPMENT OFFICER | 118,750 | $0 | 118,750 (Direct) | View |
| 2020-11-23 Conversion | 2020-11-23 4:34 pm | N/A N/A | Olema Pharmaceuticals Inc. | OLMA | Myles David C. Chief Development Officer | 167,677 | $0 | 746,667 (Indirect) | View |
| 2020-11-18 Option Award | 2020-11-19 6:59 pm | N/A 2030-11-17 | Olema Pharmaceuticals Inc. | OLMA | Myles David C. Chief Development Officer | 322,812 | $0 | 771,161 (Direct) | View |
Ownership | 2020-11-18 6:25 pm | N/A N/A | Olema Pharmaceuticals Inc. | OLMA | Myles David C. Chief Development Officer | 0 | $0 | 759,498 (Direct) | View |